Yes Bank invokes pledged shares of Asian Hotels (North) Ltd, BFSI News, ET BFSI

[ad_1]

Read More/Less


Yes Bank has acquired over 7 per cent stake in Asian Hotels (North) Ltd after invoking pledged shares as the company defaulted on loan repayments. In a regulatory filing on Friday, the lender said it has acquired 14,02,991 equity shares by way of invocation of pledge, constituting 7.21 per cent of the issue paid-up share capital of Asian Hotels (North) Ltd.

“Shares have been acquired pursuant to invocation of pledge of shares of borrower subsequent to default/breach of terms of credit facilities sanctioned by the bank to the borrower,” Yes Bank said.

The bank said the proceeds from the sale of shares will be utilised to reduce the loan secured by such shares.

Asian Hotels (North), which is into the hospitality sector, had a turnover of Rs 72.58 crore as on March 31, 2021.



[ad_2]

CLICK HERE TO APPLY

P Jayarama Bhat completes term as Chair of Karnataka Bank

[ad_1]

Read More/Less


P Jayarama Bhat, part-time non-executive Chairman of Karnataka Bank Ltd (KBL), retired from the service on Saturday after completing his term approved by the Reserve Bank of India (RBI). He took charge as part-time non-executive Chairman of Karnataka Bank on April 12 2017.

In his farewell address to staff members, Bhat said it has been a privilege and honour for him to serve Karnataka Bank for such a long period of nearly five decades in different capacities.

“I take this opportunity to thank Mahabaleshwara MS, Managing Director and Chief Executive Officer, Board of Directors, former directors and all the present and retired members of KBL family for the support given during my stint at the bank. As we approach centenary year of the bank, I am sure that Karnataka Bank will create many new benchmarks in the Indian banking industry,” he said, and welcomed Pradeep Kumar, the new Chairman of the bank.

Upgrade skill-set

Greeting the outgoing Chairman, Pradeep Kumar said it is a huge achievement in itself to serve Karnataka Bank for nearly five decades, a record not just in the history of Karnataka Bank but also in the entire Indian banking industry.

“With new players in the banking industry, it is imperative that we constantly upgrade our skill-set and knowledge to improve productivity and business generation,” he said, urging staff members to take a pledge to work with an attitude to delight the customers with their service while being vigilant and responsible about the aspects of data privacy and cyber security besides adhering to extant compliance guidelines.

Also see: Karnataka Bank sponsors ECGs for Udupi gram panchayats

Mahabaleshwara MS, Managing Director and Chief Executive Officer of the bank, said that having played such a pivotal role in the growth of the bank for a considerable period of time, Jayarama Bhat was considered as a leader par excellence in implementing the vision of the bank and in garnering the goodwill and commitment of the staff members towards attaining sustainable business. Being a true mentor and leader, Jayarama Bhat has inspired a whole generation of KBL family in taking forward the legacy of Karnataka Bank.

He said the bank is also fortunate to have Pradeep Kumar, a seasoned banker, as its new Chairman. He added that he is excited to work with him in taking the bank to still greater heights.

[ad_2]

CLICK HERE TO APPLY

5 Best Fixed Deposits To Invest For 3 To 5 Years In 2021

[ad_1]

Read More/Less


Investment

oi-Vipul Das

|

Investing in fixed deposits under the debt category, whether you are a non-senior or senior citizen, is essential to have in your portfolio when it comes to a regular flow of income with a fixed rate of return throughout the chosen maturity period. Fixed deposits, in addition to fixed interest rates, allow you to invest for a maturity term ranging from 7 days to 10 years, allowing you to meet a variety of investment objectives. Fixed deposits, on the other hand, provide a blend of capital safety and capital appreciation, since your deposits up to Rs 5 lakhs are insured by the DICGC. Despite the fact that fixed deposit interest rates have been dropping since many banks lowered their interest rates following the Reserve Bank of India’s decision to maintain the repo rate constant at 4%, here are the banks that are still offering a decent return on fixed deposits of less than Rs 2 Cr maturing in 3 to less than 5 years.

Top 5 Public Sector Banks Promising Good Returns On 3 to 5 Year FDs

Top 5 Public Sector Banks Promising Good Returns On 3 to 5 Year FDs

Based on our own research, here are the top 5 public sector banks that are offering the highest interest rates on 3 to 5 years of fixed deposits.

Banks Regular Interest Rates Interest rates for senior citizens W.e.f.
Union Bank of India 5.40% 5.90% 01/09/2021
State Bank of India 5.30% 5.80% 08.01.2021
Punjab & Sind Bank 5.30% 5.80% 16/09/2021
Punjab National Bank 5.25% 5.75% 01.08.2021
Indian Overseas Bank 5.25% 5.75% 09.11.2020
Source: Bank Website

Top 5 Private Sector Banks Offering Best Returns On 3 to 5 Year FDs

Top 5 Private Sector Banks Offering Best Returns On 3 to 5 Year FDs

Here are the top 5 private sector banks that are currently offering pretty good interest rates on deposits maturing in 3 years to less than 5 years.

Banks Regular Interest Rates Interest rates for senior citizens W.e.f.
RBL Bank 6.30% 6.80% September 01, 2021
Yes Bank 6.25% 7.00% 3rd November 2021
IndusInd Bank 6.00% 6.50% July 23rd, 2021
DCB Bank 5.95% 6.45% 17th August 2021
Axis Bank 5.40% 6.05% 10/11/2021
Source: Bank Website

Top 5 Small Finance Banks Providing Highest Interest Rates On FDs of 3 to 5 Years

Top 5 Small Finance Banks Providing Highest Interest Rates On FDs of 3 to 5 Years

On deposits of less than Rs 2 Cr maturing in 3 to 5 years, here are the top 5 small finance banks that are currently promising decent returns to both non-senior and senior citizens.

Banks Regular Interest Rates Interest rates for senior citizens W.e.f.
Jana Small Finance Bank 6.75% 7.25% 07/05/2021
Suryoday Small Finance Bank 6.50% to 6.75% 6.50% to 7.00% September 09, 2021
North East Small Finance Bank 6.50% 7.00% 19th April 2021
Fincare Small Finance Bank 6.50% to 6.25% 7.00% to 6.75% 25th October 2021
Ujjivan Small Finance Bank 6.25% 6.75% 16th August 2021
Source: Bank Website

Story first published: Saturday, November 13, 2021, 12:17 [IST]



[ad_2]

CLICK HERE TO APPLY

Dr. K.V. Subramanian, BFSI News, ET BFSI

[ad_1]

Read More/Less


India should focus on supply through reforms & capital expenditure to create assets in the economy, said Dr. K.V. Subramanian, Chief Economic Adviser, Government of India.

He was speaking about the three decades of 1991 economic reforms at the 3rd Global Finance Conclave organised by the Jindal School of Banking & Finance (JSBF) today.

Elaborating on how the economy has grown since 1991, Dr. Subramanian pointed out how the country handled the demand and supply line impact during the COVID-19 crisis. “Recognising that the COVID pandemic requires social distancing and lockdowns, it was obvious that not only would there be a demand side impact, but disruptions of the supply line chains too. While demand can actually be pushed up faster, it takes at least eight to 10 months for supply to increase. What India has done during this crisis, and I hope this will become an important macro-economic template that other countries and policymakers should study in terms of the policy response, is that India actually focused on the supply side – whether it is through the reforms or the capital expenditure. He added, “If you have an aggregate supply line not changing – you only have increasing demand. In macroeconomic terms, it means there will be a path to growth but inflation will go up as well. When inflation goes up, monetary policy has to try and unwind that demand. What you have then is the increase in demand that the fiscal policy did and the monetary policy tries to unwind it. So, you come back to square one, that push to growth that you got is a temporary one because monetary policy and fiscal policy work at cross purposes.”

The theme for the conclave is “India’s Growth Story from 1991 To 2021, And Beyond” to commemorate 30 years of the transformative 1991 reforms and to understand the challenges that need to be addressed as we slowly come out of a pandemic.

The Presidential address was by Dr. Shankar Acharya, Former Chief Economic Adviser and author of An Economist at Home and Abroad.”The once-in-century pandemic has had a major impact on the Indian economy. All indices like the GDP, unemployment, female participation in the labour force, fiscal deficit and debt were impacted. Lockdowns became a common policy during this time. This led to income/consumption losses creating a high vulnerability among the poorer sections of India. There will, however, be economic recovery even though there is still a high level of uncertainty due to the pandemic. The biggest impact has been on anon-agricultural informal sector. There have been significant policy initiatives over the last two years and they are a step in the right direction. If the effects of Covid-19 and other constraints on our medium term growth performance outweigh the reform intention, then it may lead to a period of modest growth over the next five years.”

Professor (Dr.) C. Raj Kumar, Founding Vice-Chancellor of O.P. Jindal Global University (JGU) in his inaugural address said, “The 1991 economic reforms created a new vision for India which not only impacted the economic sector and the society at large but it also created new opportunities for institution building. The idea of private higher education institutions with a view to improve the quality of education and promoting excellence is an outcome of the idea whose time had come. The reality was that though India has historically contributed to knowledge society globally, the contemporary evolution of Indian education at the dawn of Independence was limited. We only had 20 universities and today we have over 1000 universities and over 50,000 colleges. We strongly believe that there are critical elements to improving the quality of governance to improve higher education. This includes commitment to internationalization, advancing research, interdisciplinary learning, high quality faculty and equitable access to education for all. The economic reforms of 1991 that were ushered in the country led to other forms of reforms that further shaped the socio-economic future of India. Today, the National Education Policy 2020 has enormous implications with the potential of reimagining the future of Indian universities, creating an intellectual, political and social consciousness and political impetus for the improvement of higher education.”

Notable addresses were delivered by Dr. Amar Patnaik, and Dr Sasmit Patra, Members of Parliament, Rajya Sabha. Other eminent speakers at the Conclave include Ajit Pai, Distinguished Expert, Economic & Finance, Niti Aayog, Dr. Ashok K. Lahiri, Former Chief Economic Adviser, Government of India and Dr. PTR Palanivel Thiagarajan, Minister for Finance and Human Resources Management, Government of Tamil Nadu and Dr. Mukulita Vijayawargiya, Whole-Time Member of the Insolvency and Bankruptcy Board of India (IBBI).

The Global Finance Conclave will host 55 speakers including the current Chief Economic Advisor to the Government of India, 2 former Chief Economic Advisors and noted economists, 1 Minister of Finance and Human Resource Management (TN), 2 Members of Parliament (Rajya Sabha), 3 Members of State Legislative Assemblies, 1 Senior Expert from the NITI Aayog along with academics, economists, bankers and lawyers.

Dr. Ashish Bhardwaj, Professor & Dean, Jindal School of Business and Finance said, “The reforms of the 1990s changed the grammar of our country and the confidence of our people forever. Since the historic developments that happened 30 years, there is a need to reflect on the implications of India’s growth story from 1991 to 2021 and beyond. Understanding where we came from and how we emerged, will help us understand where to go from here and how to get there. Answers to these tough questions will emerge from deliberations in the Conclave. To a large extent, the fate of the world will depend on what India decides to do, how fast we do it, and how quickly we learn the lessons of the past.”

This story is provided by OP Jindal University. will not be responsible in any way for the content of this article.



[ad_2]

CLICK HERE TO APPLY

ICICI Direct Suggest To Buy This Auto Ancillary Stock For 23% Gains In A Year

[ad_1]

Read More/Less


Balkrishna Industries:

ICICI Direct has put its bet on this tyre and tubes company- Balkrishna Industries and has set a target of Rs. 2900 to be realized in 1-year. The stock last closed at a price of Rs. 2361.75, which means an upside of close to 23 percent.

About the stock: The company is a leading player in the niche tyre industry that find application in heavy machinery for agriculture as well as mining areas. The company draws major portion of its revenue i.e. as much as 80 percent from exports.

Talking about the different channels, replacement shall account for 70 percent while OEM share is at 26 percent. Agriculture accounts for 64% of volumes. Further the company has been a consistent performer with an over 20 percent margins and return ratios.

Q2Fy22 earnings of Balkrishna Industries

Q2Fy22 earnings of Balkrishna Industries

Net sales for the September ended quarter was at Rs. 2050 crore, up 13.1 per cent sequentially. EBIDTA margin declined. PAT grew 14 percent to Rs. 377 crore owing to higher additional income.

Advice on Balkrishna Industries stock by ICICI Direct

The company over the 5-year period has outperformed Nifty Auto index. “We retain BUY on Balkrishna amid robust demand prospects, healthy financials and

value the scrip at revised target price of Rs. 2,900 i.e. 32x

P/E on FY23-24E average EPS of Rs. 90.6 (earlier target price Rs. 2,825).

Key triggers for future price performance:

Key triggers for future price performance:

-The company’s aggressive plans to double its market share to 10 percent.

– There is seen robust demand across segments including agriculture, OTR for propelling volume growth.

– There is in place backward integration as well as aggressive brownfield expansion.

-Net debt free b/s, double-digit return ratios & strong cash generation

-Sales, PAT growth seen at a CAGR of 21.9%, 17.1% over FY21-24E

Alternate Stock Idea: The company in the auto ancillary space likes JK Tyre.

• Walking the talk on b/s deleveraging, sweating of assets & capital efficiency

• BUY with a target price of | 185

GoodReturns.in

Disclaimer:

Disclaimer:

This stock is picked from the brokerage report of ICICI Direct. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

This Healthcare Stock Has A “BUY” Call From Edelweiss With A Target Price of Rs 3,753

[ad_1]

Read More/Less


Q2FY22 results of Metropolis Healthcare Ltd

According to the brokerage “Metropolis Healthcare (METROHL) reported marginally miss in our estimates. Revenue grew by 5% YoY to INR 303cr, ~4% lower than our estimates. EBITDA reported INR 90cr (down ~1% YoY & ~4.5% below our estimates) and EBITDA margin of 29.8% contracted 170bps YoY vs our estimates of 30%.”

Edelweiss has said “METROHL reported non-COVID revenue of INR 260cr (up ~38% YoY and down 2% QoQ) Vs 33%/22% YoY growth for Dr Lal/Vijaya, on account of unlocking of economy and easing of covid19 restrictions. METROHL’s Q2FY22 Non-COVID realization per test/patient (up 7%/12% YoY), Non-COVID patient volume up 23% YoY and test volume up 28.6% YoY.”

Based on the research report of the brokerage the company’s “EBITDA margin contracted by 170bps YoY to 29.8% (v/s est. 30% and 28.4% of Dr Lal) and excluding CSR & ESOP expenses EBITDA margin was 30.8%. PAT reported INR 58cr (down ~3% YoY) against our estimates of INR 61cr.”

Edelweiss has clarified “METROHL’s COVID revenue down by 57% YoY to INR 43cr with the reduction in COVID cases. METROHL’s Q2FY22 Non-COVID realization per test/patient (up 7%/12% YoY), Non-COVID patient volume up 23% YoY and test volume up 28.6% YoY. Revenue contribution from specialised tests (non-covid) increased to 43% in Q2FY22 from 39% in Q2FY21. The share of B2C business (non-Covid revenue) in focus cities stood at 60% in Q2FY22, which management aims to increase to 65% in the coming years.”

Buy Metropolis Healthcare Ltd with a target price of Rs 3,753

Buy Metropolis Healthcare Ltd with a target price of Rs 3,753

Edelweiss has reported that “The company has reported results marginally lower than our estimates while non-COVID business in H1FY22 has come back strongly, revenue up 80% YoY against 54% for Dr Lal and EBITDA margin also maintained at ~30% indicates METROHL’s premium business model and dominant market share in major geographies (where it is present). The strong expansion plans along with Hitech acquisition would be healthy growth drivers for the company in the coming years. However, entry of Dr Lal through Suburban in Mumbai market would create some challenges for the company.”

The brokerage has claimed that “We have consolidated Hitech numbers in our estimates, thus, we have revised our earnings estimate upwards for FY23E by 19%, and also introduced FY24 estimates. The stock is currently trading at 62x/49x/44x FY22E/FY23E/FY24E earnings. Maintain ‘BUY’ with a revised target price of INR 3753 (earlier INR3,356) (DCF-based).”

Disclaimer

Disclaimer

The above stock is picked from the brokerage report of Edelweiss Broking Ltd. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

2 Balanced Funds For SIPs Rated No 1 By Crisil

[ad_1]

Read More/Less


Kotak Debt Hybrid Fund

This fund has been rated No 1 by Crisil in the conservative hybrid category. The fund has generated a returns of 19% in the last 1-year and the 3-year returns are 13.89% on an annualized basis.

At the moment the fund has around 56% in debt, about 23% in equities and the remaining in cash and cash equivalents. A bulk of the investment is in government securities. The assets under management are to the tune of around Rs 1,160 crores.

The minimum amount required to invest by way of SIPs is Rs 1,000. With the Sensex at around the 60,000 points level mark and with most analysts believing that the markets are over valued, moving money to conservative balanced fund SIPs may not be a bad idea. There are many investors who may have made decent money over the last 1-year or so. Kotak Debt Hybrid Fund has also been rated 5-star by Value Research.

Canara Robeco Conservative Hybrid Fund

Canara Robeco Conservative Hybrid Fund

This fund too like the Kotak Debt Hybrid Fund has been rated No 1 by CRISIL. The Canara Robeco Conservative Hybrid Fund seeks to generate to income through investment primarily in debt securities with marginal exposures in equity and money market instruments of various maturities and risk profile.

The fund has given a returns of 13.61% in the last 1-year, while the 3-year returns are close to 12.46% on an annualized basis. The assets under management are to the tune of around Rs 1,000 crores.

Investors can start an SIP with a sum of Rs 1,000 every month. The fund has also been rated 5-star by Value Research, apart from CRISIL.

Disclaimer

Disclaimer

Investors are advised caution as investing in mutual funds is risky. The report is for informational purposes and Greynium Information Technologies, the author and the brokerage would not be responsible for any losses incurred by investors based on the report above.



[ad_2]

CLICK HERE TO APPLY

2 Stocks To Buy Suggested By Edelweiss Broking Ltd For 36% Returns

[ad_1]

Read More/Less


Q2FY22 results of CreditAccess Grameen Ltd

According to Edelweiss “CreditAccess Grameen’s (CAG) reported numbers largely in-line with our estimates on the net revenues front. Higher OPEX due to branch expansion was offset by lower than expected provisions resulting in a PAT beat of 10% against our estimates. Disbursements came in above pre-covid quarterly run rate but remain below Q3/Q4FY21 levels. Oct’21 disbursements came in higher than July-Sept’21 monthly run-rate indicating strong growth momentum in H2Y22. Gross Loan Portfolio (GLP) grew by 19% YoY / 5% QoQ to INR 13,333cr driven by robust disbursements. Management has guided for a 17-19% growth in GLP for FY22 sans a covid third wave.”

Edelweiss has said in its research report that the company’s “Consolidated GS-3 remained largely steady with marginal increase of 11bps sequentially to 7.7% largely driven by MMFL Stage -3 recognition being moved to 60dpd+ from 90dpd+ in the quarter. CAG carries an overall ECL provision of INR 740cr (5.9% of loan book). Consol. restructured assets stood at ~1.3% of GLP well ahead of other MFI focused banks and NBFCMFIs which have reported results till date. Management expects credit costs to remain between 4.7-4.9% for FY22 as the company would write-off sticky stage -3 assets in H2FY22.”

Buy CreditAccess Grameen Ltd with a target price of Rs 816

Buy CreditAccess Grameen Ltd with a target price of Rs 816

The brokerage has said that “CAG has reported both growth and asset quality better than its peers and has emerged out of the pandemic in a much better position compared to peers. Incremental provisioning in H2FY22 is likely to provide a clean slate to the company to pursue growth and pre-Covid return ratios in FY23. We believe CAG is best placed to capture the structural MFI growth story with a covid third wave being the significant risk to our hypothesis. We maintain ‘BUY’ with the same target price of INR816.”

Q2FY22 results of Krishna Institute of Medical Sciences Ltd

Q2FY22 results of Krishna Institute of Medical Sciences Ltd

According to Edelweiss “KIMS’ reported a decent set of numbers with Revenue (INR 412cr up 1% YoY) miss our estimates by ~3%, however, EBITDA/PAT reported ahead of our estimates by 2%/10% to INR129cr/INR84cr. KIMS saw normalization of business as COVID-related cases came down and elective surgeries picked up. Increased Patient flow, new doctor additions in existing specialties, consistent growth in Heart and Lung transplant programme & increasing normalization of business to pre-COVID levels resulted in flat revenue.”

The company’s “Gross profit grew 4% YoY & down 10% QoQ to INR 326cr in Q2FY22 with gross margin expanded by 280bps YoY to 79.2%. EBITDA margin came in at a record level of 31.3% (v/s est. of 29.7%), mainly on account of tighter control on medical consumption cost, high occupancy and robust IP/OP volume. The acquired asset reported significant improvement in EBITDA margin to 20.7% in H1FY22 (vs 16.8% in FY21)” says Edelweiss.

Buy Krishna Institute of Medical Sciences Ltd with a target price of Rs 1,651

Buy Krishna Institute of Medical Sciences Ltd with a target price of Rs 1,651

Edelweiss has claimed in its research report that “KIMS reported good improvement in non-COVID business in Q2FY22. We maintain our positive view on KIMS, on account of robust growth in non-COVID volume & improvement in occupancy, maintained higher margins with a sustained focus on operational efficiency and strong expansion plans. The net cash at the end of the quarter stood at INR 395cr (gross debt of INR 50cr). KIMS expected to pay INR 230cr (first tranche of acquisition cost) for Sunshine Hospitals acquisition in the near term, even after that company has net cash. KIMS’s strong expansion plan for the addition of ~2,300 beds over 36-48 months will be funded through a mix of internal accrual and borrowing, with maintaining D/E at a restricted level. Maintain ‘BUY’ with a target price of INR1,651/share.”

Disclaimer

Disclaimer

The above stocks are picked from the brokerage report of Edelweiss Broking Ltd. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

2 Bank Stocks To Buy For Gains Up To 30% In 1-Year

[ad_1]

Read More/Less


Buy, Bank of Baroda stock

Current market price Rs 101.35
Target price Rs 130
Gains 28.27%

According to Emkay Global, despite lower growth/NIM, Bank of Baroda reported a strong beat on net profit at Rs 21 billion (est. Rs 10 billion), mainly aided by higher other income, DHFL recovery of Rs 8.8 billion and contained provisions.

“The gross non performing assets ratio improved by 76 bps qoq to 8.1%, while the standard net restructured book rose marginally to 3% of loans (2.9% in Q1),” the brokerage has said.

Better growth in H2 to support NIM uptick for Bank of Baroda

Better growth in H2 to support NIM uptick for Bank of Baroda

According to Emkay global, overall credit growth was moderate for Bank of Baroda at 4% yoy to Rs6.9bn due to corporate drag and sub-par retail growth.

“Within retail, mortgage growth was relatively slower, while PL was up 33% yoy and auto was up 23% yoy. Growth in gold loans was also strong at 147% yoy, albeit on a low base. According to management, corporate is seeing a pickup in Q3 with decent brownfield and working capital expansion proposals in the pipeline. The domestic CASA ratio improved slightly to 43.5%. However, slower growth and interest reversals led to a 19bps qoq compression in NIM to 2.9%. Going forward, the bank plans to improve growth/LDR, which, coupled with better traction in retail and lower interest reversals, should improve NIMs,” the brokerage has said.

Valuations and outlook for Bank of Baroda

Valuations and outlook for Bank of Baroda

Bank of Baroda remains well-capitalised with Standalone Bank CET 1 of 11.4% and easing asset quality stress, which is expected to accelerate growth, according to Emkay Global.

“This should drive up margins, which, coupled with lower LLP, should lead to gradual improvement in its RoE trajectory to 10-12% over FY23-24E from a low of 1% in FY21. Retain Buy with a revised target price of Rs 130, based on 0.8x Dec’23E ABV,” the brokerage has said.

Buy Karur Vysya Bank stock

Buy Karur Vysya Bank stock

Current market price Rs 59.95
Target price Rs 72
Gains 20.10%

The brokerage also has a buy call on the stock of Karur Vysya Bank.

“KVB reported a strong net profit beat (Rs 1.6bn vs. estimate of Rs 1 bn), mainly on better margins, lower opex (despite providing for family pension) and contained provisions.

Asset-quality performance was mixed. The GNPA ratio was down 59 bps qoq to 7.4%, but

the restructured pool inched up 120 bps to 3.2% of loans – which is reasonable vs. Peers,” the brokerage has said.

“We maintain our Buy rating with a revised Dec’22 target price of Rs72 (Rs 62 earlier), valuing the bank at 0.7x Dec’23E ABV, factoring in a better liability and capital profile; good/reasonable asset-quality performance in the current challenging times vs. peers; and an expected steady improvement in return ratios,” the brokerage has said.



[ad_2]

CLICK HERE TO APPLY

BOI conducts ‘customer outreach programme’ in Delhi, BFSI News, ET BFSI

[ad_1]

Read More/Less


New Delhi [India], November 13 (ANI): With an aim to take mainstream banking services to the people, the Bank of India has been conducting “Customer Outreach Programme”through its branches across the country to include more and more people in the mainstream banking and offer them banking services of their choice.

One first such programme was conducted at Srinagar on October 6, 2021.

According to the official release, BOI conducted another ‘Customer Outreach Programme” at its National Banking Group, New Delhi on November 11 with an attendance of over 100 customers including new and existing customers from all the branches across the New Delhi Zone.

The programme was inaugurated by Managing Director and CEO Atanu Kumar Das by opening New 116 BCs outlets at various locations in Ladakh, Delhi, Punjab and Rajasthan.

Speaking on the occasion, Das highlighted various initiatives taken by the bank under RAM (Retail, Agri and MSME) in recent times for the benefit of its customers.

He informed that the bank has recently slashed ROI for home loans and vehicle loans and has posted a net profit of 1,050.98 crores for the quarter of September 2021 marking a rise of 99.89 per cent.

He said, “BOI is committed fully to the economic revival process.”

He further added that BOI is at the forefront of successfully implementing all the government-sponsored schemes viz. MSME, Mudra, Stand-up, Start-up, PM SVANidhi schemes.

Bank has achieved 33 per cent PMSBY enrolments in PMJDY against DFS Targets 30 per cent for Q2FY21-22 and has won the “APY Annual Award (2020-21)” for overall performance for achieving ‘per APY’ target. The bank is implementing an E-PLATFORM solution for Straight through the process of major Banking products.

Das also distributed sanction letters to the beneficiary customers of various banking products viz. Housing Loan, Vehicle Loan, Stand up and Startup, MSME and PM SVANidhi schemes to the tune of ‘300cr.

It is noteworthy that during the month-long “customer outreach programmes”, the Bank of India has sanctioned ‘5000 cr and disbursed more than 4000 cr in the RAM segment alone. Another 8500 cr disbursal was done in corporate segments.

Bank intends to enrol 1500 BCs in these states during this quarter. Field General Manager Arun Kumar Jain, Zonal Manager, New Delhi Zone Ajay Kumar Panth, other senior officers and respective branch heads along with customers were present during the programme. (ANI)



[ad_2]

CLICK HERE TO APPLY

1 89 90 91 92 93 16,278